1-8 of 8
Carin A. Uyl-de Groot
Close
Sort by
Journal Articles

Outcome of Intensively Treated Elderly AML Patients Reported to the Harmony Alliance Compares Well to Outcome of Control Patients of the Prospective Randomized HOVON 103 Study in Elderly AML

Sjoerd J.F. Hermans, Jurjen Versluis, Yvette van Norden, Erik D. van Werkhoven, Jeroen J.W.M. Janssen, Gerwin A. Huls, Bob Lowenberg, Thomas Pabst, Dimitri A. Breems, Elizabeth Berkx, Avinash G. Dinmohamed, Peter C. Huijgens, Eric Sträng, Jesús María Hernández-Rivas, Hartmut Döhner, Marta Sobas, Lars Bullinger, Rosa Ayala, Joaquin Martinez-Lopez, Klaus H Metzeler, Torsten Haferlach, Christian Thiede, Carin A. Uyl-De Groot, Gert J. Ossenkoppele, Francesco Pignatti, Jan J. Cornelissen
Journal: Blood
Blood (2023) 142 (Supplement 1): 2854.
https://doi.org/10.1182/blood-2023-186277
Published: 2023
Journal Articles

The Cost of Healthcare for Pediatric Patients with Sickle Cell Disease

Maite E. Houwing, MD, Frederick Thielen, Anne P.J. de Pagter, MD PhD, Jan A Hazelzet, MD PhD, Hedwig Blommestein, Carin A. Uyl-de Groot, Marjon H. Cnossen, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1030.
https://doi.org/10.1182/blood-2019-130372
Published: 2019
Journal Articles

Lenalidomide As Maintenance Treatment for Patients with Newly Diagnosed Multiple Myeloma Post-Autologous Stem Cell Transplantation: A Pharmacoeconomic Assessment in the Netherlands

Carin A. Uyl-de Groot, Rachel Ramsden, Janneke Boersma, Sonja Zweegman, MD PhD, Sujith Dhanasiri
Journal: Blood
Blood (2018) 132 (Supplement 1): 3555.
https://doi.org/10.1182/blood-2018-99-112826
Published: 2018
Journal Articles

Systematic Literature Review and Network Meta-Analysis of Treatments for Relapsed/Refractory Multiple Myeloma Patients

Chrissy H. Y. Van Beurden-Tan, MSc, Margreet Franken, PhD, Hedwig Blommestein, PhD, Carin A. Uyl-De Groot, PhD, Pieter Sonneveld, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2144.
https://doi.org/10.1182/blood.V128.22.2144.2144
Published: 2016
Journal Articles

One Line Does Not Make a Picture: Real-World Cost-Effectiveness Of Multiple Myeloma Treatments Using a Full Disease Model

Hedwig M Blommestein, Silvia GR Verelst, Saskia de Groot, Peter C. Huijgens, MD, PhD, Pieter Sonneveld, MD, Ph.D, Carin A. Uyl-de Groot, PhD
Journal: Blood
Blood (2013) 122 (21): 2930.
https://doi.org/10.1182/blood.V122.21.2930.2930
Published: 2013
Journal Articles

Cost-Effectiveness of Treatment of Childhood Acute Lymphoblastic Leukemia with Pegasparaginase and Erwinia Asparaginase: The Impact of Expensive Chemotherapy

Wing H. Tong, MD, Inge M. van der Sluis, MD, PhD, Cathelijne Alleman, MSc, Raphaele RL van Litsenburg, MD, PhD, Gertjan Kaspers, MD, PhD, Rob Pieters, MD, PhD, Carin A. Uyl-de Groot, PhD
Journal: Blood
Blood (2012) 120 (21): 4227.
https://doi.org/10.1182/blood.V120.21.4227.4227
Published: 2012
Journal Articles

Cost-Effectiveness of Rituximab As Maintenance Treatment for Relapsed Follicular Lymphoma: Results of a Population Based Study

Hedwig M Blommestein, Djamila E Issa, MD, Marjolein Pompen, PhD, Cédric Révil, Mels Hoogendoorn, MD, PhD, Peter Joosten, MD, Sonja Zweegman, MD, PhD, Peter C. Huijgens, MD, PhD, Carin A. Uyl-de Groot, PhD
Journal: Blood
Blood (2012) 120 (21): 4277.
https://doi.org/10.1182/blood.V120.21.4277.4277
Published: 2012
Journal Articles

Cost of Autologous and Allogeneic Stem Cell Transplantations for Hematological Disease: A Dutch Multicenter Daily Practice Study

Hedwig M Blommestein, Silvia GR Verelst, Jan J Cornelissen, MD, PhD, Peter C Huijgens, MD, PhD, Nicole MA Blijlevens, MD, PhD, Carin A Uyl-de Groot, PhD
Journal: Blood
Blood (2011) 118 (21): 2079.
https://doi.org/10.1182/blood.V118.21.2079.2079
Published: 2011